Loeb S - Search Results

1

Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.

Loeb S, Zhu X, Schroder FH, Roobol MJ. Loeb S, et al. BJU Int. 2012 Dec;110(11):1678-83. doi: 10.1111/j.1464-410X.2012.11367.x. Epub 2012 Sep 21. BJU Int. 2012. PMID: 22998182 Clinical Trial.

2

Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography.

Loeb S, Han M, Roehl KA, Antenor JA, Catalona WJ. Loeb S, et al. J Urol. 2005 Jan;173(1):63-5. doi: 10.1097/01.ju.0000145883.01068.5f. J Urol. 2005. PMID: 15592029

3

Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.

Nadler RB, Loeb S, Roehl KA, Antenor JA, Eggener S, Catalona WJ. Nadler RB, et al. Among authors: loeb s. J Urol. 2005 Dec;174(6):2154-7, discussion 2157. doi: 10.1097/01.ju.0000181213.07447.8f. J Urol. 2005. PMID: 16280754

4

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

Loeb S, Roehl KA, Antenor JA, Catalona WJ, Suarez BK, Nadler RB. Loeb S, et al. Urology. 2006 Feb;67(2):316-20. doi: 10.1016/j.urology.2005.08.040. Epub 2006 Jan 25. Urology. 2006. PMID: 16442597

5

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.

Loeb S, Gonzalez CM, Roehl KA, Han M, Antenor JA, Yap RL, Catalona WJ. Loeb S, et al. J Urol. 2006 Mar;175(3 Pt 1):902-6. doi: 10.1016/S0022-5347(05)00327-7. J Urol. 2006. PMID: 16469576

6

Viewpoint: expanding prostate cancer screening.

Catalona WJ, Loeb S, Han M. Catalona WJ, et al. Among authors: loeb s. Ann Intern Med. 2006 Mar 21;144(6):441-3. doi: 10.7326/0003-4819-144-6-200603210-00012. Ann Intern Med. 2006. PMID: 16549857

7

Making prostate-specific antigen testing more effective.

Catalona WJ, Loeb S. Catalona WJ, et al. Among authors: loeb s. Urol Oncol. 2006 May-Jun;24(3):177-9. doi: 10.1016/j.urolonc.2005.09.001. Urol Oncol. 2006. PMID: 16678045 No abstract available.

8

Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.

Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ. Loeb S, et al. Urology. 2006 Jul;68(1):99-103. doi: 10.1016/j.urology.2006.02.004. Epub 2006 Jun 27. Urology. 2006. PMID: 16806410

9

Comparison of methods for calculating prostate specific antigen velocity.

Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, Catalona WJ. Yu X, et al. Among authors: loeb s. J Urol. 2006 Dec;176(6 Pt 1):2427-31; discussion 2431. doi: 10.1016/j.juro.2006.08.006. J Urol. 2006. PMID: 17085120

10

Characteristics of patients with familial versus sporadic prostate cancer.

Roehl KA, Loeb S, Antenor JA, Corbin N, Catalona WJ. Roehl KA, et al. Among authors: loeb s. J Urol. 2006 Dec;176(6 Pt 1):2438-42; discussion 2442. doi: 10.1016/j.juro.2006.07.159. J Urol. 2006. PMID: 17085123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results